Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07393204
Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCL
Sponsor: Andrés José Maria Ferreri
View on ClinicalTrials.gov
Summary
This study describes the effectiveness of epcoritamab outside the clinical trial setting in pts with DLBCL relapsed or refractory after 2 or more previous lines of therapy
Official title: Italian Real-world Study on Epcoritamab in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2025-12-10
Completion Date
2026-12-10
Last Updated
2026-02-06
Healthy Volunteers
No
Locations (1)
IRCCS Ospedale San Raffaele
Milan, Italy